Last reviewed · How we verify
Rachianesthesia
At a glance
| Generic name | Rachianesthesia |
|---|---|
| Also known as | Bupivacaine and sufentanil |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Superiority Randomized Controlled Trial of Ultrasound-guided PENG Block Compared to Surgical Infiltration in the Analgesia of Posterior Total Hip Arthroplasty Surgery (NA)
- Comparison of Two Analgesic Strategies After Scheduled Caesarean (PHASE4)
- Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rachianesthesia CI brief — competitive landscape report
- Rachianesthesia updates RSS · CI watch RSS
- GCS Ramsay Santé pour l'Enseignement et la Recherche portfolio CI